Clearside Biomedical Inc at JMP Securities Life Sciences Conference Transcript
Good morning, everybody. My name is Jon Wolleben, senior analyst here at JMP Securities, and we're pleased to kick off my day with Clearside Biomedical. And we have Tom Ciulla, Chief Medical and Development Officer, from Clearside joining us today. So thanks for coming, Tom.
Thanks for having me. I'm excited to be here.
Questions & Answers
So maybe to start, some people may not be as familiar with Clearside and the story. Can you give us the high-arching strategy that you have at the company?
Sure. So we specialize in suprachoroidal delivery of drugs. We have been working on suprachoroidal delivery for a number of years. Excited to say that, last October, we got our first asset approved; it's called XIPERE. It's being commercialized
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
